Immunomodulatory therapies in bacterial community-acquired pneumonia: Current evidence and future directions

Luke Flower, Charlotte Summers

Open source

DOI
10.1016/j.cmi.2026.10.031
Published
2026-10
Container
Clinical Microbiology and Infection
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.cmi.2026.10.031,
  title = {Immunomodulatory therapies in bacterial community-acquired pneumonia: Current evidence and future directions},
  author = {Luke Flower and Charlotte Summers},
  year = {2026},
  journal = {Clinical Microbiology and Infection},
  doi = {10.1016/j.cmi.2026.10.031},
  url = {https://doi.org/10.1016/j.cmi.2026.10.031}
}

RIS

TY  - JOUR
TI  - Immunomodulatory therapies in bacterial community-acquired pneumonia: Current evidence and future directions
AU  - Luke Flower
AU  - Charlotte Summers
PY  - 2026
JO  - Clinical Microbiology and Infection
DO  - 10.1016/j.cmi.2026.10.031
UR  - https://doi.org/10.1016/j.cmi.2026.10.031
ER  - 

APA

Flower, L., & Summers, C. (2026). Immunomodulatory therapies in bacterial community-acquired pneumonia: Current evidence and future directions. Clinical Microbiology and Infection. https://doi.org/10.1016/j.cmi.2026.10.031

Source records